Since CREB is known to induce proliferation through its anti-oxidative role [131,132], this calls us to speculate that the role of Epac in lung cancer may be attributed to CREB-mediated inhibition of ROS production. The gene discussed is RAPGEF4; the disease is lung carcinoma.